OAXLB0104 The ADVANCE trial: Phase 3, randomised comparison of TAF/FTC+DTG, TDF/FTC+DTG or TDF/FTC/EFV for first-line treatment of HIV-1 infectionOral abstract session with live Q&AB30
OAXLB0105 The first long-term remission of chronic HIV-1 infection without myeloablation?Oral abstract session with live Q&AA18
PEB0278 Viral suppression by delivery and birth outcomes among pregnant women living with HIV using dolutegravir in the United States: A comparative effectiveness and safety analysisPoster ExhibitionB44
PEC0453 Frailty in HIV-positive and HIV-negative individuals across the adulthood and its association with comorbidity, depressive symptoms and sleep disordersPoster ExhibitionC12
PEC0663 Factor analysis of HIV prevention interventions for high-risk adolescent girls and young women in the DREAMS (Determined Resilient Empowered AIDS-free Mentored and Safe) program in Uganda (2016-2019)Poster ExhibitionC39
PUB001 Refugee resilience as a pathway for HIV preventionPublication OnlyD51
PUB002 HIV status disparities in substance use disorder treatment need and utilization among adults in the United States, 2015-2018: Implications for healthcare service accessPublication OnlyD46
seek-warrow-warrow-eseek-e2291 - 2297 of 2297 items